Innovus Pharmaceuticals (OTC:INNV) said today that its GlucoGorx glucose monitoring kit, which includes a glucose meter, test strips and a lancet device, won 510(k) approval from the FDA.
The San Diego, Calif.-based company plans to launch its blood sugar monitoring kit in the second half of this year.
Get the full story at our sister site, Drug Delivery Business News.